RCAI-56, a carbocyclic analogue of KRN7000: its synthesis and potent activity for natural killer (NK) T cells to preferentially produce interferon-γ

Tetrahedron Letters

Volumn 48, Issue 19, 2007, Pages 3343-3347

  Tashiro, Takuya ^a   Nakagawa, Ryusuke ^a   Hirokawa, Takatsugu ^b   Inoue, Sayo ^a   Watarai, Hiroshi ^a   Taniguchi, Masaru ^a   Mori, Kenji ^a  

^a RIKEN   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; CARBA ALPHA DEXTRO GALACTOSE DERIVATIVE; CD1D ANTIGEN; CYTOKINE; DRUG ANALOG; GAMMA INTERFERON; METHYL ALPHA DEXTRO GALACTOPYRANOSIDE; PALLADIUM; PYRANOSIDE; RCAI 56; SULFAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; REACTION ANALYSIS; TH1 CELL;

MUS;

EID: 34247164956     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.03.074     Document Type: Article

References (26)

1. Morita M., Motoki K., Akimoto K., Natori T., Sakai T., Sawa E., Yamaji K., Koezuka Y., Kobayashi E., and Fukushima H. J. Med. Chem. 38 (1995) 2176-2187
2. Natori T., Koezuka Y., and Higa T. Tetrahedron Lett. 34 (1993) 5591-5592
3. Natori T., Morita M., Akimoto K., and Koezuka Y. Tetrahedron 50 (1994) 2771-2776
4. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., and Taniguchi M. Science 278 (1997) 1626-1629
5. Wu D., Xing G.-W., Poles M.A., Horowitz A., Kinjo Y., Sullivan B., Bodmer-Narkevitch V., Plettenburg O., Kronenberg M., Tsuji M., Ho D.D., and Wong C.-H. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1351-1356
6. Rissoan M.-C., Soumelis V., Kadowaki N., Grouard G., Briere F., Malefyt R.deW., and Liu Y.-J. Science 283 (1999) 1183-1186
7. Savage P.B., Teyton L., and Bendelac A. Chem. Soc. Rev. 35 (2006) 771-779
8. Franck R.W., and Tsuji M. Acc. Chem. Res. 39 (2006) 692-701
9. Berkers C.R., and Ovaa H. Trends Pharmacol. Sci. 26 (2005) 252-257
10. Schmieg J., Yang G., Franck R.W., and Tsuji M. J. Exp. Med. 198 (2003) 1631-1641
11. Yang G., Schmieg J., Tsuji M., and Franck R.W. Angew. Chem., Int. Ed. 43 (2004) 3818-3822
12. Chen G., Schmieg J., Tsuji M., and Franck R.W. Org. Lett. 6 (2004) 4077-4080
13. Wipf P., and Pierce J.G. Org. Lett. 8 (2006) 3375-3378
14. Zajonc D.M., Cantu III C., Mattner J., Zhou D., Savage P.B., Bendelac A., Wilson I.A., and Teyton L. Nat. Immunol. 6 (2005) 810-818
15. Koch M., Stronge V.S., Shepherd D., Gadola S.D., Mathew B., Ritter G., Fersht A.R., Besra G.S., Schmidt R.R., Jones E.Y., and Cerundolo V. Nat. Immunol. 6 (2005) 819-826
16. Yu S.-H., Park J.-J., and Chung S.-K. Tetrahedron: Asymmetry 17 (2006) 3030-3036
17. Sun C., and Bittman R. J. Org. Chem. 69 (2004) 7694-7699
18. Das S.K., Mallet J.-M., and Sinaÿ P. Angew. Chem., Int. Ed. 36 (1997) 493-496
19. Iimori T., Takahashi H., and Ikegami S. Tetrahedron Lett. 37 (1996) 649-652
20. Ko K.-S., Zea C.J., and Pohl N.L. J. Am. Chem. Soc. 126 (2004) 13188-13189
21. 16
22. Heidelberg T., and Martin O.R. J. Org. Chem. 69 (2004) 2290-2301
23. 3) ppm.
24. The serum samples were obtained at indicated times after the injection of KRN7000 (1) or RCAI-56 (3). Concentration was measured by ELISA (Cytometric Bead Array system; BD Bioscience).
25. 14 using Glide 4.0 (Schrödinger, LLC). Initial structures of 1 and 3 were built based on co-crystallized ligands PBS and R16 in mCD1d. Hydrogen-bonding interaction between the ligands and the mCD1d and their visualization were generated by MacPyMOL (DeLano Scientific, LLC).
26. Friesner R.A., Banks J.L., Murphy R.B., Halgren T.A., Klicic J.J., Mainz D.T., Repasky M.P., Knoll E.H., Shelley M., Perry J.K., Shaw D.E., Francis P., and Shenkin P.S. J. Med. Chem. 47 (2004) 1739-1749